THRX
Income statement / Annual
Last year (2022), Theseus Pharmaceuticals, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2022, Theseus Pharmaceuticals, Inc.'s net income was -$47.08 M.
See Theseus Pharmaceuticals, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$438,000.00 |
$2,000.00 |
$2,000.00 |
$2,000.00 |
| Gross Profit |
-$438,000.00 |
-$2,000.00 |
-$2,000.00 |
-$2,000.00 |
| Gross Profit Ratio |
0 |
0 |
0 |
0 |
| Research and Development
Expenses |
$35.70 M
|
$18.33 M
|
$5.96 M
|
$4.12 M
|
| General & Administrative
Expenses |
$18.39 M
|
$9.01 M
|
$878,000.00
|
$818,000.00
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$18.39 M
|
$9.01 M
|
$878,000.00
|
$818,000.00
|
| Other Expenses |
$3.48 M |
$28,000.00 |
-$5.16 M |
-$2.24 M |
| Operating Expenses |
$54.09 M |
$27.34 M |
$6.84 M |
$4.94 M |
| Cost And Expenses |
$54.09 M |
$27.34 M |
$6.84 M |
$4.94 M |
| Interest Income |
$0.00 |
$28.00 |
$0.00 |
$0.00 |
| Interest Expense |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$50,000.00
|
$2,000.00
|
$2,000.00
|
$2,000.00
|
| EBITDA |
-$54.09 M
|
-$27.33 M
|
-$6.83 M
|
-$4.94 M
|
| EBITDA Ratio |
0 |
0 |
0 |
0 |
| Operating Income Ratio
|
0
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
$3.48 M
|
$28,000.00
|
-$5.16 M
|
-$2.24 M
|
| Income Before Tax |
-$50.61 M |
-$27.31 M |
-$12.00 M |
-$7.18 M |
| Income Before Tax Ratio
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
-$3.53 M |
$0.00 |
$0.00 |
$0.00 |
| Net Income |
-$47.08 M |
-$27.31 M |
-$12.00 M |
-$7.18 M |
| Net Income Ratio |
0 |
0 |
0 |
0 |
| EPS |
-1.22 |
-2.84 |
-0.47 |
-0.6 |
| EPS Diluted |
-1.22 |
-2.84 |
-0.47 |
-0.6 |
| Weighted Average Shares
Out |
$38.49 M
|
$9.63 M
|
$25.37 M
|
$11.92 M
|
| Weighted Average Shares
Out Diluted |
$38.49 M
|
$9.63 M
|
$25.37 M
|
$11.92 M
|
| Link |
|
|
|
|
